Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders

Journal of Lipid Research

Volumn 57, Issue 7, 2016, Pages 1144-1154

  Ferrell, Jessica M ^a   Boehme, Shannon ^a   Li, Feng ^b   Chiang, John Y L ^a  

^a Northeastern Ohio Medical University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; TRIACYLGLYCEROL; CHOLESTEROL; CYP7A1 PROTEIN, MOUSE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BODY COMPOSITION; CONTROLLED STUDY; EXCRETION; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIVER METABOLISM; LUNG GAS EXCHANGE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTING METABOLIC RATE; WEIGHT GAIN; WESTERN DIET; ANIMAL; DISEASE MODEL; ENZYMOLOGY; EXHALATION; GENETICS; HOMEOSTASIS; HUMAN; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXHALATION; GLUCOSE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIVER; METABOLIC DISEASES; MICE;

EID: 84977090702     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M064709     Document Type: Article

References (40)

1. Chiang, J. Y. L. 2009. Bile acids: regulation of synthesis. J. Lipid Res. 50: 1955-1966.
2. Sayin, S. I., A. Wahlström, J. Felin, S. Jäntti, H. U. Marschall, K. Bamberg, B. Angelin, T. Hyötyläinen, M. Orešič, and F. Bäckhed. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17: 225-235.
3. Vlahcevic, Z. R., R. T. Stravitz, D. M. Heuman, P. B. Hylemon, and W. M. Pandak. 1997. Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology. 113: 1949-1957.
4. Duane, W. C., and N. B. Javitt. 1999. 27-Hydroxycholesterol: production rates in normal human subjects. J. Lipid Res. 40: 1194-1199.
5. Li, T., and J. Y. L. Chiang. 2014. Bile acid signaling in metabolic disease and drug therapy. Pharmacol. Rev. 66: 948-983.
6. Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell. 6: 507-515.
7. Song, K-H., T. Li, E. Owsley, S. Strom, and J. Y. L. Chiang. 2009. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression. Hepatology. 49: 297-305.
8. Li, T., J. M. Francl, S. Boehme, A. Ochoa, Y. Zhang, C. D. Klaassen, S. K. Erickson, and J. Y. L. Chiang. 2012. Glucose and insulin induction of bile acid synthesis: mechanisms and implications in diabetes and obesity. J. Biol. Chem. 287: 1861-1873.
9. Qi, Y., C. Jiang, J. Cheng, K. W. Krausz, T. Li, J. M. Ferrell, F. J. Gonzalez, and J. Y. L. Chiang. 2015. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice. Biochim. Biophys. Acta. 1851: 19-29.
10. Broeders, E. P., E. B. Nascimento, B. Havekes, B. Brans, K. H. Roumans, A. Tailleux, G. Schaart, M. Kouach, J. Charton, B. Deprez, et al. 2015. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 22: 418-426.
11. Prawitt, J., S. Caron, and B. Staels. 2014. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization. Trends Endocrinol. Metab. 25: 235-244.
12. Kobayashi, M., H. Ikegami, T. Fujisawa, K. Nojima, Y. Kawabata, S. Noso, N. Babaya, M. Itoi-Babaya, K. Yamaji, Y. Hiromine, et al. 2007. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes. 56: 239-247.
13. Ma, K., P. K. Saha, L. Chan, and D. D. Moore. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116: 1102-1109.
14. Pournaras, D. J., C. Glicksman, R. P. Vincent, S. Kuganolipava, J. Alaghband-Zadeh, D. Mahon, J. H. Bekker, M. A. Ghatei, S. R. Bloom, J. R. Walters, et al. 2012. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 153: 3613-3619.
15. Albaugh, V. L., C. R. Flynn, S. Cai, Y. Xiao, R. A. Tamboli, and N. N. Abumrad. 2015. Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids. J. Clin. Endocrinol. Metab. 100: E1225-E1233.
16. Flynn, C. R., V. L. Albaugh, S. Cai, J. Cheung-Flynn, P. E. Williams, R. M. Brucker, S. R. Bordenstein, Y. Guo, D. H. Wasserman, and N. N. Abumrad. 2015. Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat. Commun. 6: 7715.
17. Ishibashi, S., M. Schwarz, P. K. Frykman, J. Herz, and D. W. Russell. 1996. Disruption of cholesterol 7α-hydroxylase gene in mice: I. Postnatal lethality reversed by bile acid and vitamin supplementation. J. Biol. Chem. 271: 18017-18023.
18. Erickson, S. K., S. R. Lear, S. Deane, S. Dubrac, S. L. Huling, L. Nguyen, J. S. Bollineni, S. Shefer, H. Hyogo, D. E. Cohen, et al. 2003. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7a1-deficient mice. J. Lipid Res. 44: 1001-1009.
19. Jones, R. D., J. J. Repa, D. W. Russell, J. M. Dietschy, and S. D. Turley. 2012. Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1-/- mice fed low levels of cholic acid. Am. J. Physiol. Gastrointest. Liver Physiol. 303: G263-G274.
20. Jones, R. D., A. M. Lopez, E. Y. Tong, K. S. Posey, J. C. Chuang, J. J. Repa, and S. D. Turley. 2015. Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice. Steroids. 93: 87-95.
21. Li, T., E. Owsley, M. Matozel, P. Hsu, C. M. Novak, and J. Y. L. Chiang. 2010. Transgenic expression of cholesterol 7α-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology. 52: 678-690.
22. Li, T., M. Matozel, S. Boehme, B. Kong, L-M. Nilsson, G. Guo, E. Ellis, and J. Y. L. Chiang. 2011. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology. 53: 996-1006.
23. Woolbright, B. L., K. Dorko, D. J. Antoine, J. I. Clarke, P. Gholami, F. Li, S. C. Kumer, T. M. Schmitt, J. Forster, F. Fan, et al. 2015. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol. Appl. Pharmacol. 283: 168-177.
24. Heuman, D. M. 1989. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J. Lipid Res. 30: 719-730.
25. Xu, G., B. L. Shneider, S. Shefer, L. B. Nguyen, A. K. Batta, G. S. Tint, M. Arrese, S. Thevananther, L. Ma, S. Stengelin, et al. 2000. Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits. J. Lipid Res. 41: 298-304.
26. Horton, J. D., J. C. Cohen, and H. H. Hobbs. 2009. PCSK9: a convertase that coordinates LDL catabolism. J. Lipid Res. 50: S172-S177.
27. Kersten, S. 2014. Integrated physiology and systems biology of PPARα. Mol. Metab. 3: 354-371.
28. Hou, X., S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, et al. 2008. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283: 20015-20026.
29. Haeusler, R. A., B. Astiarraga, S. Camastra, D. Accili, and E. Ferrannini. 2013. Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids. Diabetes. 62: 4184-4191.
30. Kong, B., L. Wang, J. Y. Chiang, Y. Zhang, C. D. Klaassen, and G. L. Guo. 2012. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology. 56: 1034-1043.
31. Wang, D. Q-H., S. Tazuma, D. E. Cohen, and M. C. Carey. 2003. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G494-G502.
32. Zhang, Y., F. Y. Lee, G. Barrera, H. Lee, C. Vales, F. J. Gonzalez, T. M. Willson, and P. A. Edwards. 2006. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. USA. 103: 1006-1011.
33. McLean, J. A., and G. Tobin. 1987. Animal and Human Calorimetry. Cambridge University Press, Cambridge, UK.
34. Wang, D. Q-H., F. Lammert, D. E. Cohen, B. Paigen, and M. C. Carey. 1999. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am. J. Physiol. 276: G751-G760.
35. Hall, E. A., S. Ren, P. B. Hylemon, D. Rodriguez-Agudo, K. Redford, D. Marques, D. Kang, G. Gil, and W. M. Pandak. 2005. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. Biochim. Biophys. Acta. 1733: 111-119.
36. Rodriguez-Agudo, D., S. Ren, E. Wong, D. Marques, K. Redford, G. Gil, P. Hylemon, and W. M. Pandak. 2008. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J. Lipid Res. 49: 1409-1419.
37. Sinha, J., F. Chen, T. Miloh, R. C. Burns, Z. Yu, and B. L. Shneider. 2008. beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G996-G1003.
38. Li, H., F. Chen, Q. Shang, L. Pan, B. L. Shneider, J. Y. L. Chiang, B. M. Forman, M. Ananthanarayanan, G. S. Tint, G. Salen, et al. 2005. FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G60-G66.
39. Ratziu, V., V. de Ledinghen, F. Oberti, P. Mathurin, C. Wartelle-Bladou, C. Renou, P. Sogni, M. Maynard, D. Larrey, L. Serfaty, et al. 2011. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J. Hepatol. 54: 1011-1019.
40. Staels, B. 2009. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus. Postgrad. Med. 121: 25-30.